Douglas Shander

Randomized, double‐blind clinical evaluation of the efficacy and safety of topical eflornithine HCl 13.9% cream in the treatment of women with facial hair

John E. Wolf, Douglas Shander, Ferdinand Huber et al. · International Journal of Dermatology · 2006 · 144 citations

Facial Hair, Topical Drug, Clinical Dermatology +4

Identification of Inhibin-Like Activity in Ovarian Venous Plasma of Rats during the Estrous Cycle

Louis V. DePaolo, Douglas Shander, Phyllis M. Wise et al. · Endocrinology · 1979 · 98 citations

Plasma Fsh, Fsh Secretion, Gynecology +23

Differences in Expression of Specific Biomarkers Distinguish Human Beard from Scalp Dermal Papilla Cells

Susan Rutberg, Meredith L. Kolpak, John A. Gourley et al. · Journal of Investigative Dermatology · 2006 · 51 citations · Full text

Cutaneous Biology, Pathology, Dermatology +4

Interactions of Porcine Follicular Fluid with Ovarian Steroids and Luteinizing Hormone-Releasing Hormone on the Secretion of Luteinizing Hormone and Follicle-Stimulating Hormone by Cultured Pituitary Cells

Douglas Shander, Larry Anderson, C. A. Barraclough et al. · Endocrinology · 1980 · 49 citations

Human Growth, Fsh Secretion, Gynecology +22

The effect of eflornithine 13.9% cream on the bother and discomfort due to hirsutism*

J. Jaime, Graciela Caro, Frances Garfield et al. · International Journal of Dermatology · 2007 · 49 citations